Tower Research Capital LLC (TRC) - ARTELO BIOSCIENCES INC ownership

ARTELO BIOSCIENCES INC's ticker is ARTL and the CUSIP is 04301G201. A total of 4 filers reported holding ARTELO BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ARTELO BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$2,000
-77.8%
4,856
-75.4%
0.00%
Q1 2022$9,000
+200.0%
19,723
+261.2%
0.00%
Q4 2021$3,000
-62.5%
5,461
-44.8%
0.00%
Q3 2021$8,000
+100.0%
9,902
+199.7%
0.00%
Q2 2021$4,000
+100.0%
3,304
+154.2%
0.00%
Q1 2021$2,000
+100.0%
1,300
+85.7%
0.00%
Q2 2020$1,0000.0%700
+176.7%
0.00%
Q3 2019$1,000253
+583.8%
0.00%
Q2 2019$0370.00%
Other shareholders
ARTELO BIOSCIENCES INC shareholders Q2 2020
NameSharesValueWeighting ↓
KEYSTONE WEALTH PARTNERS 15,000$7,0000.00%
Snowden Capital Advisors LLC 110,000$49,0000.00%
Virtu Financial LLC 23,801$11,0000.00%
UBS Group AG 18,283$8,0000.00%
WELLS FARGO & COMPANY/MN 260$00.00%
NORTHERN TRUST CORP 62,521$28,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 167,826$75,0000.00%
STATE STREET CORP 13,039$6,0000.00%
CREATIVE FINANCIAL DESIGNS INC /ADV 1,075$00.00%
View complete list of ARTELO BIOSCIENCES INC shareholders